Therapeutic potential of combined viral transduction and CRISPR/Cas9 gene editing in treating neurodegenerative diseases

被引：0
|
作者：
Joshua Kuruvilla
Andrew Octavian Sasmita
Anna Pick Kiong Ling
机构：
[1] International Medical University,Division of Applied Biomedical Sciences and Biotechnology, School of Health Sciences
来源：
Neurological Sciences | 2018年 / 39卷
关键词：
CRISPR/Cas9; Demyelination; Gene editing; Molecular neuroscience; Neurodegeneration;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1827 / 1835
页数：8
相关论文
共 50 条
  • [1] Therapeutic potential of combined viral transduction and CRISPR/Cas9 gene editing in treating neurodegenerative diseases
    Kuruvilla, Joshua
    Sasmita, Andrew Octavian
    Ling, Anna Pick Kiong
    NEUROLOGICAL SCIENCES, 2018, 39 (11) : 1827 - 1835
  • [2] CRISPR/CAS9 GENOME EDITING FOR NEURODEGENERATIVE DISEASES
    Nojadeh, Jafar Nouri
    Eryilmaz, Nur Seren Bildiren
    Erguder, Berrin Imge
    EXCLI JOURNAL, 2023, 22 : 567 - 582
  • [3] Application of the gene editing tool, CRISPR-Cas9, for treating neurodegenerative diseases
    Kolli, Nivya
    Lu, Ming
    Maiti, Panchanan
    Rossignol, Julien
    Dunbar, Gary L.
    NEUROCHEMISTRY INTERNATIONAL, 2018, 112 : 187 - 196
  • [4] The Potential of CRISPR/Cas9 Gene Editing as a Treatment Strategy for Inherited Diseases
    Abdelnour, Sameh A.
    Xie, Long
    Hassanin, Abdallah A.
    Zuo, Erwei
    Lu, Yangqing
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [5] CRISPR/CAS9 GENE EDITING
    不详
    CHEMICAL & ENGINEERING NEWS, 2015, : 26 - 27
  • [6] Therapeutic gene editing in haematological disorders with CRISPR/Cas9
    Jensen, Trine I.
    Axelgaard, Esben
    Bak, Rasmus O.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 (05) : 821 - 835
  • [7] Therapeutic applications of CRISPR/Cas9 gene editing technology for the treatment of ocular diseases
    Sundaresan, Yogapriya
    Yacoub, Sam
    Kodati, Bindu
    Amankwa, Charles E.
    Raola, Akash
    Zode, Gulab
    FEBS JOURNAL, 2023, 290 (22) : 5248 - 5269
  • [8] CRISPR/Cas9 novel therapeutic road for the treatment of neurodegenerative diseases
    Karimian, Ansar
    Gorjizadeh, Negar
    Alemi, Forough
    Asemi, Zatollah
    Azizian, Khalil
    Soleimanpour, Jafar
    Malakouti, Faezeh
    Targhazeh, Niloufar
    Majidinia, Maryam
    Yousefi, Bahman
    LIFE SCIENCES, 2020, 259
  • [9] Therapeutic potential of CRISPR/Cas9 mediated in vivo gene editing for primary hyperoxaluria
    Zabaleta, N.
    Barberia, M.
    Zapata-Linares, N.
    Rodriguez, S.
    Olaguee, C.
    Vales, A.
    Abizanda, G.
    Iglesias, E.
    Salido, E.
    Prosper, F.
    Gonzalez-Aseguinolaza, G.
    Rodriguez-Madoz, J. R.
    HUMAN GENE THERAPY, 2016, 27 (11) : A139 - A140
  • [10] Therapeutic Crispr/Cas9 Genome Editing for Treating Sickle Cell Disease
    Park, So Hyun
    Lee, Ciaran M.
    Deshmukh, Harshavardhan
    Bao, Gang
    BLOOD, 2016, 128 (22)
12345